Your browser doesn't support javascript.
loading
Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
Heller, Danielle R; Chiu, Alexander S; Farrell, Kaitlin; Killelea, Brigid K; Lannin, Donald R.
Affiliation
  • Heller DR; Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA. d.heller@yale.edu.
  • Chiu AS; Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA. alex.chiu@yale.edu.
  • Farrell K; The Breast Center/Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA. kaitlinfarrell10@gmail.com.
  • Killelea BK; The Breast Center/Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA. Brigid.killelea@yale.edu.
  • Lannin DR; The Breast Center/Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA. Donald.lannin@yale.edu.
Cancers (Basel) ; 11(4)2019 Apr 08.
Article in En | MEDLINE | ID: mdl-30965658
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Incidence_studies / Risk_factors_studies / Screening_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Incidence_studies / Risk_factors_studies / Screening_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Country of publication: